undamentalytics Newsletter
Sign in

Aptiv (APTV) stock

Add to watchlist

Add holding +

NYSE: APTV NYSE Automotive Parts & Equipment Next results ~November 3, 2026

Aptiv is a global industrial technology company that develops hardware and software supporting automation, electrification and digitalisation across the automotive and other industries. Its products span from sensor to cloud, including intelligent sensors, high-performance compute platforms and advanced software through its Advanced Safety and User Experience unit; connection systems, high-performance interconnects and cable management through its Engineered Components Group; and low- and high-voltage power, signal and data distribution through its Electrical Distribution Systems unit.

It sells to vehicle manufacturers, supplying products and services under purchase orders governed by each manufacturer's terms, typically for the life of a vehicle programme. Customers include the 25 largest automotive original equipment manufacturers, as well as aerospace and defence companies and global telecom operators.

The business is organised into three reportable segments and operates through a regional service model, with 139 major manufacturing facilities and 11 major technical centres, a presence in 50 countries and about 140,000 employees. Aptiv plans to separate its Electrical Distribution Systems business into an independent listed company named Versigent.

Based on Aptiv's 10-K filed February 6, 2026.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Aptiv valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders4 buying, 4 selling8 purchases and 7 sales by directors and officers, last 12 monthsInsider trades
  • Funds318 adding, 372 cuttingOf 76 active managers that changed their stake, 40 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Aptiv files

Where Aptiv stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $18.7bn, up 5.3% on a year earlier, faster than -5.0% a quarter earlier. Free-cash-flow margin fell to 3.7% from 9.8% a year earlier. Operating margin narrowed to 5.3% from 9.9%. The diluted share count is down 7.5% on a year earlier, which lifts each remaining share. It passes 2 of our 7 financial-health checks.

Our model value for Aptiv is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 3, 2026 (estimated)

Aptiv's trailing-twelve-month revenue grew 5.3% year on year, with a free-cash-flow margin of 3.7%.

Our discounted-cash-flow model values the business at ~$63 per share in the base case (~$40–$93 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 60.6% while net income fell 78.3%: a 18pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Growth speeding up. The growth rate is 10.3 points higher than a quarter earlier.
  • Shrinking share count. Diluted shares fell 7.5% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Margins narrowing. Operating margin is down 4.6 points on a year ago.
  • High earnings multiple. The shares trade at 43 times the last 12 months' earnings, so expectations are demanding.
  • Short interest rising. Shares sold short rose 26% in a month to 6.1% of tradable shares.

Latest results: FY2026 Q2

Filed August 4, 2026
Earnings per share
$1.63 against an average estimate of $1.43: beat by 14.1%
Revenue
$3.27bn, up 2.3% on a year earlier
Share reaction
-17.9% in the first session after the results on August 4, 2026, against +1.6% for the S&P 500
Guidance given
net sales $3,120m to $3,220m (Q3 2026); net sales $12,600m to $12,800m (Full Year 2026)
Next report
November 3, 2026; average EPS estimate $1.32

Aptiv's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.7%
  • 1 week+1.4%
  • 1 month+1.6%
  • This year-41.9%
  • 1 year-45.5%
  • 5 years-75.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$18.7B
Operating margin
5.3%
Net margin
1.2%
EPS (TTM, diluted)
$1.02

Growth

Revenue growth
+5.3%
Change in growth rate
+10.3 pts
Share count change
−7.5%

Cash

Free cash flow (TTM)
$684M
FCF margin
3.7%
Stock pay % of revenue
0.7%

Earnings

Last results
August 4, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Product
  3. Results
  4. Announcement
  5. Announcement
  6. Insider trade
  7. Insider trade
  8. Results
  9. Guidance
  10. Partnership
  11. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Aptiv valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Aptiv as an operating company, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1.02 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$55 ~$47–$70 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$53 ~$39–$73 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$57 ~$50–$67 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Aptiv with Automotive Parts & Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$68.42$54.72$83.33$60.77$94.73$130.29$164.95$93.13$89.72$60.48$76.09$44.23
Market value$19.6bn$15.0bn$22.3bn$16.1bn$24.4bn$35.3bn$44.7bn$25.3bn$25.4bn$15.5bn$16.8bn$9.5bn
+ Net debt (− = net cash)$3.6bn$3.2bn$2.6bn$4.1bn$4.3bn$1.4bn$936m$5.1bn$4.7bn$7.4bn$6.1bn$4.6bn
Enterprise value$23.2bn$18.2bn$24.9bn$20.2bn$28.7bn$36.6bn$45.7bn$30.3bn$30.0bn$22.9bn$22.9bn$14.1bn
Multiples
Price / sales 1.8x1.2x1.7x1.1x1.7x2.7x2.9x1.4x1.3x0.8x0.8x0.5x
Price / earnings 13.5x11.9x16.5x15.1x24.6x19.6x75.8x42.5x8.6x8.7x101.8x43.2x
Price / free cash flow 16.3x11.7x29.0x20.6x28.9x42.5x73.2x60.3x25.6x9.6x11.0x13.9x
EV / EBITDA 14.7x9.0x12.7x9.4x14.4x12.7x23.3x15.0x12.2x8.2x10.5x7.3x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

54 /100

Moderate moat

How hard Aptiv's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 11 / 20

    Cash operating profit has been a median 8.9% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 18.2%, moving by 2.4 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median 9.4%; its worst year was 5.2%.

  • Cash conversion 12 / 20

    Free cash flow was positive in 9 of 10 years, at a median 5.0% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 20.7% over five years; stock-based pay has been a median 0.5% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (59 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 3, 2026, before the open. Analysts expect revenue of $3.2bn and EPS of $1.32 (range $1.18 to $1.40) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $5.69 −27% $12.7bn −38%
Next $6.47 +14% $13.2bn +4%

Next year's EPS estimate has moved −4.6% in 90 days, across 18 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −3.9% on 90 days ago. In the last 30 days, 0 analysts raised Aptiv's forecast and 4 cut it.

Consensus EPS forecast Aptiv, last 90 days
$5.50 $6.00 $6.50 $7.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $5.92 Current fiscal year, 60 days ago: $5.72 Current fiscal year, 30 days ago: $5.73 Current fiscal year, 7 days ago: $5.69 Current fiscal year, Now: $5.69 $5.69 Next fiscal year, 90 days ago: $6.78 Next fiscal year, 60 days ago: $6.51 Next fiscal year, 30 days ago: $6.55 Next fiscal year, 7 days ago: $6.47 Next fiscal year, Now: $6.47 $6.47

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $5.92$6.78
60 days ago $5.72$6.51
30 days ago $5.73$6.55
7 days ago $5.69$6.47
Now $5.69$6.47

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $1.43 $1.63 +14.1%
Mar 2026 $1.58 $1.71 +7.9%
Dec 2025 $1.86 $1.86 +0.2%
Sept 2025 $1.83 $2.17 +18.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 4, 2026
  • Net sales Full Year 2026 $12,600m to $12,800m
    “Net sales $3,120 - $3,220 $12,600 - $12,800” source
  • Net sales Q3 2026 $3,120m to $3,220m
    “Net sales $3,120 - $3,220 $12,600 - $12,800” source
  • U.S. GAAP diluted net income per share from continuing operations Full Year 2026 $4.06 to $4.26 GAAP
    “U.S. GAAP diluted net income per share from continuing operations $0.86 - $0.96 $4.06 - $4.26” source
  • Adjusted net income per share Full Year 2026 $5.60 to $5.80 Non-GAAP
    “Adjusted net income per share $1.25 - $1.35 $5.60 - $5.80” source
  • U.S. GAAP diluted net income per share from continuing operations Q3 2026 $0.86 to $0.96 GAAP
    “U.S. GAAP diluted net income per share from continuing operations $0.86 - $0.96 $4.06 - $4.26” source
  • Adjusted net income per share Q3 2026 $1.25 to $1.35 Non-GAAP
    “Adjusted net income per share $1.25 - $1.35 $5.60 - $5.80” source
Show 12 more items
  • U.S. GAAP net income from continuing operations Full Year 2026 $860m to $900m GAAP
    “U.S. GAAP net income from continuing operations $180 - $200 $860 - $900” source
  • U.S. GAAP net income from continuing operations margin Full Year 2026 about 6.9% GAAP
    “U.S. GAAP net income from continuing operations margin 6.0% 6.9%” source
  • Adjusted EBITDA Full Year 2026 $2,310m to $2,370m Non-GAAP
    “Adjusted EBITDA $545 - $575 $2,310 - $2,370” source
  • Adjusted EBITDA margin Full Year 2026 about 18.4% Non-GAAP
    “Adjusted EBITDA margin 17.7% 18.4%” source
  • Cash flow from continuing operations Full Year 2026 $1,270m to $1,370m
    “Cash flow from continuing operations $1,270 - $1,370” source
  • Free cash flow Full Year 2026 $625m to $725m Non-GAAP
    “Free cash flow $625 - $725” source
  • U.S. GAAP effective tax rate Full Year 2026 about 18% GAAP
    “U.S. GAAP effective tax rate ~18%” source
  • Adjusted effective tax rate Full Year 2026 about 18% Non-GAAP
    “Adjusted effective tax rate ~18%” source
  • U.S. GAAP net income from continuing operations Q3 2026 $180m to $200m GAAP
    “U.S. GAAP net income from continuing operations $180 - $200 $860 - $900” source
  • U.S. GAAP net income from continuing operations margin Q3 2026 about 6% GAAP
    “U.S. GAAP net income from continuing operations margin 6.0% 6.9%” source
  • Adjusted EBITDA Q3 2026 $545m to $575m Non-GAAP
    “Adjusted EBITDA $545 - $575 $2,310 - $2,370” source
  • Adjusted EBITDA margin Q3 2026 about 17.7% Non-GAAP
    “Adjusted EBITDA margin 17.7% 18.4%” source

How earlier guidance turned out

  • U.S. GAAP diluted net income per share, Q2 2026 guided $0.65 to $0.85 Above range: $1.17
  • U.S. GAAP net income, Q2 2026 guided $140m to $180m Above range: $248m
  • Net sales, Q2 2026 guided $3,200m to $3,400m Within range: $3,274m

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

20 analysts, Oct 2026
Buy1680%
Hold420%
Sell00%

Monthly trend

  1. Oct 2026511420
  2. Sep 2026511420
  3. Aug 2026611320
  4. Jul 202671220

Counts of recommendations published by analysts covering Aptiv, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.1%
of tradable shares
Days to cover
2.71
at average volume
Short interest, 1 month
+26%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.8%
of shares
Employees
140,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −45.5%

$81.10 on October 31, 2025 to $44.23

ThenNowEffect
Revenue (last 12 months) $17.8bn $18.7bn +5.3%
Net margin 5.7% 1.2% −79.4%
P/E multiple 18.6x 43.2x +132.2%
Share count 232m 215m +8.2%

Biggest factor: net margin.

Last 3 years −42.9%

$77.50 on November 3, 2023 to $44.23

ThenNowEffect
Revenue (last 12 months) $19.3bn $18.7bn −2.8%
Net margin 5.0% 1.2% −76.3%
P/E multiple 22.1x 43.2x +95.8%
Share count 272m 215m +26.4%

Biggest factor: net margin.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
APTV+27%−44%−4%−33%+26%−42%
Industry peers (median)+15%−29%+11%−19%+23%−5%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
APTV67%25%42%42%58%27%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
APTV−16%−55%−41%−42%−29%−52%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 76% from November 3, 2021 to October 23, 2026. Getting back needed a 317% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$42.69 – $88.67
From 52-week high
−50.1%
vs 50-day average
−0.7%
vs 200-day average
−25.7%
Volatility (1 year)
43%
Beta vs S&P 500
1.15

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±6.9%
After a week
5 up, 7 down
typical move ±8.2%
After a month
7 up, 5 down
typical move ±13.0%
Results releasedNext dayS&P 500 next day5 days21 days
August 4, 2026 −17.9% +1.6% −13.3% −21.3%
May 5, 2026 −4.6% +2.2% −7.7% +22.5%
February 2, 2026 +3.2% −0.4% +10.1% −3.1%
October 30, 2025 −5.4% −0.8% −4.3% −10.3%
July 31, 2025 −1.5% −2.0% −1.3% +19.3%
May 1, 2025 +3.3% +2.2% +7.1% +14.4%
February 6, 2025 +4.6% −0.6% +8.4% +5.0%
January 22, 2025 +3.4% +1.1% +1.4% +7.9%
October 31, 2024 −18.4% −1.5% −19.4% −18.8%
August 1, 2024 +0.3% −3.3% −0.6% +3.1%
May 2, 2024 +15.9% +2.2% +20.0% +21.4%
January 31, 2024 −3.7% −0.3% −5.4% −8.8%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Aptiv
$17B $18B $19B $20B $21B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $19.8B Revenue (TTM), FY23 Q4: $20.1B Revenue (TTM), FY24 Q1: $20.1B Revenue (TTM), FY24 Q2: $20B Revenue (TTM), FY24 Q3: $19.7B Revenue (TTM), FY24 Q4: $19.7B Revenue (TTM), FY25 Q1: $19.6B Revenue (TTM), FY25 Q2: $17.8B Revenue (TTM), FY25 Q3: $18.1B Revenue (TTM), FY25 Q4: $18.4B Revenue (TTM), FY26 Q1: $18.7B Revenue (TTM), FY26 Q2: $18.7B $18.7B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $19.8B
FY23 Q4 $20.1B
FY24 Q1 $20.1B
FY24 Q2 $20B
FY24 Q3 $19.7B
FY24 Q4 $19.7B
FY25 Q1 $19.6B
FY25 Q2 $17.8B
FY25 Q3 $18.1B
FY25 Q4 $18.4B
FY26 Q1 $18.7B
FY26 Q2 $18.7B
Revenue growth, TTM YoY Aptiv
-20% -10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 16.4% Revenue growth, TTM YoY, FY23 Q4: 14.6% Revenue growth, TTM YoY, FY24 Q1: 11.1% Revenue growth, TTM YoY, FY24 Q2: 3.7% Revenue growth, TTM YoY, FY24 Q3: -0.2% Revenue growth, TTM YoY, FY24 Q4: -1.7% Revenue growth, TTM YoY, FY25 Q1: -2.5% Revenue growth, TTM YoY, FY25 Q2: -11.0% Revenue growth, TTM YoY, FY25 Q3: -8.0% Revenue growth, TTM YoY, FY25 Q4: -6.7% Revenue growth, TTM YoY, FY26 Q1: -5.0% Revenue growth, TTM YoY, FY26 Q2: 5.3% 5.3%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 16.4%
FY23 Q4 14.6%
FY24 Q1 11.1%
FY24 Q2 3.7%
FY24 Q3 -0.2%
FY24 Q4 -1.7%
FY25 Q1 -2.5%
FY25 Q2 -11.0%
FY25 Q3 -8.0%
FY25 Q4 -6.7%
FY26 Q1 -5.0%
FY26 Q2 5.3%
Operating margin (TTM) Aptiv
4% 6% 8% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 8.3% Operating margin (TTM), FY23 Q4: 7.8% Operating margin (TTM), FY24 Q1: 8.1% Operating margin (TTM), FY24 Q2: 8.3% Operating margin (TTM), FY24 Q3: 8.7% Operating margin (TTM), FY24 Q4: 9.3% Operating margin (TTM), FY25 Q1: 9.5% Operating margin (TTM), FY25 Q2: 9.9% Operating margin (TTM), FY25 Q3: 5.9% Operating margin (TTM), FY25 Q4: 5.6% Operating margin (TTM), FY26 Q1: 5.1% Operating margin (TTM), FY26 Q2: 5.3% 5.3%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 8.3%
FY23 Q4 7.8%
FY24 Q1 8.1%
FY24 Q2 8.3%
FY24 Q3 8.7%
FY24 Q4 9.3%
FY25 Q1 9.5%
FY25 Q2 9.9%
FY25 Q3 5.9%
FY25 Q4 5.6%
FY26 Q1 5.1%
FY26 Q2 5.3%
FCF margin (TTM) Aptiv
2% 4% 6% 8% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 6.7% FCF margin (TTM), FY23 Q4: 4.9% FCF margin (TTM), FY24 Q1: 6.2% FCF margin (TTM), FY24 Q2: 6.8% FCF margin (TTM), FY24 Q3: 5.8% FCF margin (TTM), FY24 Q4: 8.2% FCF margin (TTM), FY25 Q1: 8.7% FCF margin (TTM), FY25 Q2: 9.8% FCF margin (TTM), FY25 Q3: 9.8% FCF margin (TTM), FY25 Q4: 8.3% FCF margin (TTM), FY26 Q1: 5.8% FCF margin (TTM), FY26 Q2: 3.7% 3.7%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 6.7%
FY23 Q4 4.9%
FY24 Q1 6.2%
FY24 Q2 6.8%
FY24 Q3 5.8%
FY24 Q4 8.2%
FY25 Q1 8.7%
FY25 Q2 9.8%
FY25 Q3 9.8%
FY25 Q4 8.3%
FY26 Q1 5.8%
FY26 Q2 3.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Aptiv took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $20.4B
  2. Cost of revenue $16.5B · 80.9%
  3. Gross profit $3.9B · 19.1%
  4. Research and development $1.1B · 5.5%
  5. Selling, general and admin $1.7B · 8.2%
  6. Operating income $1.2B · 5.8%
  7. Income tax $700M · 3.4%
  8. Interest and other $319M · 1.6%
  9. Net income $165M · 0.8%

Shares of revenue. Source: Aptiv's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 13.8 16.0 15.5 15.1 15.5 10.9 12.3 12.9 14.4 14.4 13.1 15.6 17.5 20.1 19.7 20.4 18.7
Gross profit — 2.7 2.7 2.9 3.0 3.0 2.7 2.6 2.7 2.6 1.9 2.4 2.6 3.4 3.7 3.9 3.7
EBITDA 1.4 2.1 2.0 2.1 2.3 1.6 2.0 2.0 2.1 2.0 2.9 2.0 2.0 2.5 2.8 2.2 1.9
Operating income 0.9 1.6 1.5 1.6 1.8 1.2 1.5 1.4 1.5 1.3 2.1 1.2 1.3 1.6 1.8 1.2 1.0
Net income 0.6 1.1 1.1 1.2 1.4 1.5 1.3 1.4 1.1 1.0 1.8 0.6 0.6 2.9 1.8 0.2 0.2
Diluted EPS $0.92 $2.72 $3.33 $3.89 $4.48 $5.06 $4.59 $5.06 $4.02 $3.85 $6.66 $1.94 $1.96 $10.39 $6.96 $0.75 $1.02
Growth (year on year)
Revenue — +16.1% −3.3% −3.0% +3.0% −29.9% +13.0% +5.0% +12.0% −0.5% −9.0% +19.5% +12.0% +14.6% −1.7% +3.5% +5.3%
EBITDA — +55.7% −7.4% +8.4% +8.1% −31.3% +28.4% −3.3% +9.5% −7.3% +44.6% −31.9% +3.2% +22.0% +13.6% −22.5% −27.5%
Operating income — +74.9% −10.2% +10.2% +8.1% −29.7% +24.6% −8.0% +4.0% −13.4% +66.0% −43.9% +6.2% +23.4% +18.2% −35.7% −43.3%
Net income — +81.5% −5.9% +12.5% +11.5% +7.3% −13.3% +7.8% −21.3% −7.2% +82.2% −67.3% +0.7% +394.6% −39.2% −90.8% −78.3%
Diluted EPS — +195.7% +22.4% +16.8% +15.2% +12.9% −9.3% +10.2% −20.6% −4.2% +73.0% −70.9% +1.0% +430.1% −33.0% −89.2% −76.5%
Margins
Gross margin — 16.6% 17.1% 19.2% 19.5% 27.7% 22.4% 20.3% 18.9% 18.4% 14.8% 15.6% 15.1% 17.2% 18.8% 19.1% 19.6%
EBITDA margin 9.9% 13.2% 12.6% 14.1% 14.8% 14.5% 16.5% 15.2% 14.9% 13.9% 22.1% 12.6% 11.6% 12.3% 14.2% 10.7% 10.4%
Operating margin 6.8% 10.2% 9.5% 10.8% 11.3% 11.4% 12.5% 11.0% 10.2% 8.9% 16.2% 7.6% 7.2% 7.8% 9.3% 5.8% 5.3%
Net margin 4.6% 7.1% 6.9% 8.1% 8.7% 13.3% 10.2% 10.5% 7.4% 6.9% 13.8% 3.8% 3.4% 14.7% 9.1% 0.8% 1.2%
Free-cash-flow margin 4.6% 4.7% 5.0% 7.6% 8.7% 11.0% 10.5% 6.0% 5.4% 5.9% 6.3% 3.9% 2.4% 4.9% 8.2% 7.5% 3.7%
Cash flow
Cash from operations 1.1 1.4 1.5 1.8 2.1 1.7 1.9 1.5 1.6 1.6 1.4 1.2 1.3 1.9 2.4 2.2 1.4
Capital spending 0.5 0.6 0.7 0.6 0.8 0.5 0.7 0.7 0.8 0.8 0.6 0.6 0.8 0.9 0.8 0.7 0.7
Free cash flow 0.6 0.7 0.8 1.1 1.4 1.2 1.3 0.8 0.8 0.8 0.8 0.6 0.4 1.0 1.6 1.5 0.7
Stock-based pay −0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Free cash flow after stock pay 0.6 0.7 0.8 1.1 1.3 1.1 1.2 0.7 0.7 0.8 0.8 0.5 0.3 0.9 1.5 1.4 0.6
Balance sheet
Cash 3.2 1.4 1.1 1.3 0.9 0.4 0.7 1.6 0.6 0.4 2.8 3.1 1.5 1.6 1.6 1.6 0.8
Total debt 0.0 2.2 2.6 2.5 2.5 4.1 4.0 4.2 4.7 4.8 4.2 4.1 6.6 6.3 9.0 7.7 5.4
Net debt (negative = net cash) −3.2 0.8 1.5 1.1 1.6 3.6 3.2 2.6 4.1 4.3 1.4 0.9 5.1 4.7 7.4 6.1 4.6
Diluted shares 686m 421m 323m 312m 302m 287m 274m 268m 265m 257m 271m 271m 271m 283m 257m 221m 215m
Returned to shareholders
Dividends — 0.0 0.0 0.2 0.3 0.3 0.3 0.3 0.2 0.0 0.0 0.1 0.0 — — — —
Buybacks 0.0 0.0 0.4 0.5 1.0 1.2 0.6 0.4 0.5 0.4 0.1 0.0 0.0 0.4 4.1 0.4 0.7
Total returned 0.0 0.0 0.4 0.7 1.3 1.4 1.0 0.7 0.7 0.4 0.1 0.1 0.0 0.4 4.1 0.4 0.7

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 7 checks passed · June 30, 2026
What it owns · $18.0bn
Short-term assets $6.0bnLonger-term assets $12.0bn
What it owes, and who funded it · $18.0bn
Short-term liabilities $3.0bnLonger-term liabilities $6.3bnShareholders' equity $8.8bn
  • Short-term assets cover short-term liabilities $6.0bn of assets due within a year against $3.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $6.0bn short-term assets against $6.3bn of longer-dated liabilities.
  • More cash than debt $761m of cash against $5.4bn of debt.
  • Debt below 40% of shareholders' equity Debt is 61% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 49% to 61% over five years.
  • A year's operating cash flow covers at least 20% of debt $1.4bn of operating cash flow against $5.4bn of debt.
  • Operating profit covers interest at least five times over Operating income of $995m against $328m of interest.

From Aptiv's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$719M
Buybacks, last 3 fiscal years
$4.9B
Diluted share count
−7.5%
year over year
Total shareholder yield
7.8%
dividends 0.0% + buybacks 7.8% of market value
Sales & admin spending
8.8%
of revenue
Days sales outstanding
47 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in automotive parts & equipment
Last 12 months unless stated APTV ADNT LEA BWA ALV MGA Median
Revenue, last 12 months $18.7bn $15.1bn $23.8bn $14.2bn $11.1bn $42.0bn $2.6bn
Revenue growth, last 12 months 5.3% 5.0% 3.5% 0.4% 4.3% −1.9% 5.0%
Revenue growth, 3-year average −1.0% −0.4% 1.1% 0.6% 3.2% 6.4% 1.3%
Revenue growth, latest quarter 2.3% 5.0% 1.6% −2.9% −0.5% — 2.2%
Gross margin 19.6% 6.3% 6.9% 19.6% 19.0% 14.3% 19.9%
Operating margin 5.3% — 3.7% 5.4% 9.1% — 5.6%
Operating margin, 3-year average 7.8% — 3.7% 5.6% 9.3% — 6.0%
Net margin 1.2% 0.3% 2.5% 3.4% 5.6% 2.0% 3.4%
Cash from operations / revenue 7.2% 3.8% 5.7% 11.8% 10.3% 8.6% 7.2%
Free-cash-flow margin 3.7% 2.0% 2.9% 8.1% 6.6% 5.4% 3.7%
Free-cash-flow margin, 3-year average 6.7% 1.9% 2.7% 7.7% 5.6% 4.6% 5.5%
Stock pay / revenue 0.7% 0.0% 0.3% 0.4% — 0.1% 0.7%
Change in share count −7.5% −6.9% −5.5% −4.6% −3.9% −1.5% −0.1%

Median of all 27 companies we cover in automotive parts & equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue YoY
North America $7.6B ▲ 6.0%
United States $7.4B ▲ 6.2%
EMEA $6.6B ▲ 1.2%
Asia Pacific $5.9B ▲ 2.6%
Germany $1.6B ▲ 0.4%
South America $392M ▲ 8.6%
Other North America $207M 0.0%

These categories overlap or exclude eliminations, so shares aren't shown.

From Aptiv's 10-K filed February 6, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$12.8B
Institutions reporting
651
Shares held vs prior quarter
▲ 8.6%
Positions opened / closed
68 / 111

Top buyers and sellers, Q2 2026: 318 institutions bought and 372 sold ; the biggest buyer was Massachusetts Financial Services Co (+6.6M shares) and the biggest seller UBS Am, A Distinct Business Unit Of UBS Asset Management Americas LLC (−4.9M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.1B 18.0M 8.6% ▼ 5.2%
Vanguard Capital Management LLC $851M 13.9M 6.6% 0.0%
Barrow Hanley Mewhinney & Strauss LLC $663M 10.8M 5.2% ▲ 107.4%
State Street Corp $582M 9.5M 4.5% ▼ 3.1%
Vanguard Portfolio Management LLC $548M 8.9M 4.3% ▼ 1.0%
Norges Bank $482M 7.8M 3.8% —
Massachusetts Financial Services Co $474M 7.5M 3.7% ▲ 785.3%
Geode Capital Management, LLC $358M 5.9M 2.8% ▲ 0.6%
Hotchkis & Wiley Capital Management LLC $301M 4.9M 2.3% ▲ 43.4%
Viking Global Investors LP $279M 4.6M 2.2% New
Nordea Investment Management AB $271M 4.5M 2.1% ▼ 3.7%
FMR LLC $258M 4.2M 2.0% ▲ 43.4%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Aptiv's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $8.9M 8 trades by 4 insiders, last 12 months Insider sales History → $4M 7 trades by 4 insiders · 100% under pre-set plans
Net ▲ $4.9M net buying
Insider Date Trade Shares Price Value
Agnevall Hakan Director August 13, 2026 Buy 4,100 $48.58 $199,182
Mahoney Sean O Director August 11, 2026 Buy 1,000 $50.28 $50,280
Mahoney Sean O Director August 11, 2026 Buy 6,000 $50.21 $301,255
Mahoney Sean O Director August 11, 2026 Buy 4,000 $50.29 $201,148
Clark Kevin P Chair and CEO August 10, 2026 Buy 51,190 $48.89 $2.5M
Meister Paul M Director August 5, 2026 Buy 105,631 $47.33 $5M
Louissaint Obed D. EVP & Chief People Officer June 15, 2026 Sell pre-set plan 3,000 $69.60 $208,800
Ramundo Katherine H EVP, CLO, CCO & Secretary June 3, 2026 Sell pre-set plan 2,000 $78.30 $156,600
Agnevall Hakan Director May 8, 2026 Buy 6,100 $57.73 $352,153
Ramundo Katherine H EVP, CLO, CCO & Secretary January 8, 2026 Sell pre-set plan 5,000 $85.00 $425,000
Agnevall Hakan Director December 12, 2025 Buy 3,700 $80.25 $296,918
Laroyia Varun EVP & Chief Financial Officer December 12, 2025 Sell pre-set plan 5,000 $80.05 $400,250

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 24 trades and filings

No trades in Aptiv disclosed in the last 12 months; 24 earlier trades on record.

  • Jefferson Shreve(R-IN 6):Sale (full), $15,001 - $50,000, traded May 12, 2025, filed June 22, 2025
  • Jefferson Shreve(R-IN 6):Sale (partial), $15,001 - $50,000, traded May 8, 2025, filed June 22, 2025
  • Jefferson Shreve(R-IN 6):Purchase, $15,001 - $50,000, traded April 7, 2025, filed May 8, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around October 29, 2026 estimated from the company's past filing pattern, not announced

  • August 4, 2026
  • May 5, 2026
  • February 2, 2026
  • October 30, 2025
  • July 31, 2025
  • May 1, 2025

Recent SEC filings

Data status

When each part of this page on Aptiv was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Aptiv in brief

What does Aptiv do?
Aptiv is a US-listed company in the automotive parts & equipment industry. Its financial year ends in December.
What is Aptiv's stock ticker?
Aptiv trades under the ticker APTV on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Aptiv's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Aptiv reported revenue of $18.7B, 5.3% higher than a year earlier, according to its SEC filings.
What is Aptiv's free cash flow?
Aptiv's free-cash-flow margin is 3.7% of revenue over the trailing twelve months.
Who are Aptiv's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and Barrow Hanley Mewhinney & Strauss LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Aptiv buying back stock, and does it pay a dividend?
Aptiv spent $719M on share repurchases over the trailing twelve months, and its diluted share count fell 7.5% over the year.
What is Aptiv's market cap?
On November 2, 2026, Aptiv's market capitalisation was about $9.5B, with a price-to-earnings ratio of 43.2 and net debt of $4.6B. Market figures come from third-party market data and may be delayed.
How much debt does Aptiv have?
Aptiv's debt-to-equity ratio is 61.2%, from its latest balance sheet (48.6% five years earlier). The financial health section below sets out its other solvency checks.
Who are Aptiv's competitors?
In our Automotive Parts & Equipment peer group, the companies closest to Aptiv are Adient plc, Lear Corp, Borgwarner Inc, Autoliv Inc and Magna International Inc. The side-by-side comparison below sets their revenue, margins and growth against Aptiv's.
Are insiders buying or selling Aptiv stock?
Over the last 12 months, Aptiv's directors and officers reported 8 open-market purchases and 7 sales on Form 4. The insider trading page charts every trade.
When is Aptiv's next earnings date?
Around November 3, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Aptiv announces its own schedule.